Analyzers with the purchase of cartridges specific for patient testing.

Active Awarded Last action

Contract number
HT940625FE004
Awardee
Awarding agency
Obligated
$275,583

Award facts

Contract value 18% obligated
  • $275,583.40 Current, with exercised options
  • $1,523,217.40 Potential, with all options
Completion date 21% complete
Current and potential, with all options
Contracting staff
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6632 Analysis Instruments, Medical Laboratory Use
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Portsmouth, VA 23708, USA

Award details come from SAM.gov/FPDS.

About this award

Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1.52M by the Defense Health Agency on September 1, 2025, for the delivery of analyzers and patient-testing cartridges. The contract is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule and carries a firm fixed price structure with no set-aside designation, indicating full and open competition. Performance will be executed at the contractor's facility in Portsmouth, Virginia, with an ultimate completion date of February 28, 2031. This delivery order represents a continuation of Abbott's established relationship with the Defense Health Agency in providing critical diagnostic equipment and consumable testing supplies essential to military healthcare operations.

As a child contract under the broader GSA Schedule vehicle, this delivery order leverages Abbott's established expertise in point-of-care testing and diagnostic technologies. The Defense Health Agency, which operates the military health system serving active duty personnel, retirees, and their families, relies on such diagnostic capabilities to support clinical operations across military treatment facilities. Abbott's selection through this mechanism reflects its proven capability to deliver reliable analytical instruments and associated reagents at scale, consistent with the company's broader federal contracting portfolio, which demonstrates substantial experience supplying comparable diagnostic solutions to the Department of Veterans Affairs and other federal healthcare customers.

Quick answers

Who was awarded contract HT940625FE004?

HT940625FE004 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on September 1, 2025.

How much is contract HT940625FE004 worth?

The government has obligated $275,583 on HT940625FE004. Its potential value, with all options, is $1,523,217.

Is contract HT940625FE004 an order under another contract?

Yes. HT940625FE004 is a delivery order under V797P7322A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract HT940625FE004 competed?

The extent of competition for HT940625FE004 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award